Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Solid lipid nanoparticles (SLN) - Effects of lipid composition on in vitro degradation and in vivo toxicity
Publication

Publications

Solid lipid nanoparticles (SLN) - Effects of lipid composition on in vitro degradation and in vivo toxicity

Title
Solid lipid nanoparticles (SLN) - Effects of lipid composition on in vitro degradation and in vivo toxicity
Type
Article in International Scientific Journal
Year
2006
Authors
Weyhers, H
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Ehlers, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Hahn, H
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Souto, EB
(Author)
Other
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Muller, RH
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
The Journal is awaiting validation by the Administrative Services.
Title: PHARMAZIEImported from Authenticus Search for Journal Publications
Vol. 61
Pages: 539-544
ISSN: 0031-7144
Indexing
Other information
Authenticus ID: P-00F-S99
Abstract (EN): Solid lipid nanoparticles (SLN) composed of two different lipid matrices were produced to assess their in vivo toxicity in mice. Matrix substances were (i) Compritol (glycerol behenate), a physiological lipid with GRAS status (generally recognized as safe [FDA]), and (ii) cetyl palmitate, a less physiological compound. Physicochemical data proved the suitability of SLN batches for intravenous administration. To assess the in vivo toxicity of produced batches, 400 ¿l SLN dispersion (lipid content 10% [m/m]) were administered to mice via a bolus injection for six times within a period of 20 days (high dose administration). Additionally, a multiple low dose administration was performed with Compritol-SLN as well (200 ¿l SLN dispersion, lipid content 2.5% [m/m]). Hepatic and splenic tissues were analysed histologically. In vivo results were dependent on the lipid matrix, as well as on the dose administered. For cetyl palmitate containing SLN no pathological results were obtained, while high dosed Compritol containing formulations led to accumulation of the lipid in liver and spleen and subsequently to pathological alterations. These alterations were found to be partially reversible within six weeks after completing intravenous administration. Liver architecture was nearly recovered. In contrast, low dosed Compritol SLN were well tolerated. Lipid accumulation and pathological alterations of high dosed Compritol SLN were attributed to the slow degradation of the Compritol matrix which could be shown by performing in vitro studies in human plasma.
Language: English
Type (Professor's evaluation): Scientific
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Solid lipid nanoparticles (SLN) - Effects of lipid composition on in vitro degradation and in vivo toxicity (2006)
Article in International Scientific Journal
Weyhers, H; Ehlers, S; Hahn, H; Sout, EB; Muller, RH

Of the same journal

Lipid nanoemulsions for anti-cancer drug therapy (2011)
Another Publication in an International Scientific Journal
Souto, EB; Nayak, AP; Murthy, RSR
Validation of an UV spectrophotometric assay for the quantification of polymyxin B in solid lipid nanoparticles (2015)
Article in International Scientific Journal
Severino, P; Silveira, EF; Vazzana, M; Chaud, MV; Santana, MHA; Souto, EB
The use of SLN (R) and NLC (R) as topical particulate carriers for imidazole antifungal agents (2006)
Article in International Scientific Journal
Souto, EB; Muller, RH
The use of SLN® and NLC® as topical participate carriers for imidazole antifungal agents (2006)
Article in International Scientific Journal
Souto, EB; Muller, RH
Solid lipid nanoparticles (SLN) - Effects of lipid composition on in vitro degradation and in vivo toxicity (2006)
Article in International Scientific Journal
Weyhers, H; Ehlers, S; Hahn, H; Sout, EB; Muller, RH

See all (12)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-18 at 11:04:46 | Privacy Policy | Personal Data Protection Policy | Whistleblowing